According to a new market research report published by Global Market
Estimates, the Global Circulating Cell-Free DNA (ccfDNA)
Diagnostics Market is projected to grow from USD 4.9 billion in 2022
to USD 13.1 billion in 2027 at a CAGR of 21.7% from 2022 to 2027.
Browse 153 Market Data
Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global
Circulating Cell-Free DNA (ccfDNA) Diagnostics Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/circulating-cell-free-dna-ccfdna-diagnostics-market-3851
Hoffmann-La Roche, Natera Inc., Illumina Inc., Agena Bioscience, Paragon
Genomics, Thermo Fisher Scientific, Bio-Rad Laboratories, Lucence Health, and Eurofins among others are some key players in the
circulating cell-free DNA (ccfDNA) diagnostics market.
Application Outlook (Revenue, USD
Billion, 2022-2027)
·
Non-invasive Prenatal Testing
·
Cancer Diagnostics
·
Others
Type Outlook (Revenue, USD Billion, 2022-2027)
·
Hospitals & Prenatal Clinics
·
Diagnostic Centers
·
Academic & Government Institutes
·
Biotechnology & Pharmaceutical Companies
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
Europe
Asia Pacific
Central & South America
Middle East & Africa
Contact:
Yash Jain
Email
address: yash.jain@globalmarketestimates.com
Phone
Number: +1 6026667238